Yuka Tanaka

2.2k total citations
140 papers, 1.7k citations indexed

About

Yuka Tanaka is a scholar working on Immunology, Surgery and Epidemiology. According to data from OpenAlex, Yuka Tanaka has authored 140 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Immunology, 41 papers in Surgery and 34 papers in Epidemiology. Recurrent topics in Yuka Tanaka's work include Immune Cell Function and Interaction (49 papers), T-cell and B-cell Immunology (28 papers) and Renal Transplantation Outcomes and Treatments (25 papers). Yuka Tanaka is often cited by papers focused on Immune Cell Function and Interaction (49 papers), T-cell and B-cell Immunology (28 papers) and Renal Transplantation Outcomes and Treatments (25 papers). Yuka Tanaka collaborates with scholars based in Japan, United States and Switzerland. Yuka Tanaka's co-authors include Hideki Ohdan, Toshimasa Asahara, Takashi Onoe, Kohei Ishiyama, Kentaro Ide, Masahiro Ohira, Hirotaka Tashiro, Hiroshi Mitsuta, Hiroyuki Tahara and Daisuke Tokita and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yuka Tanaka

128 papers receiving 1.7k citations

Peers

Yuka Tanaka

IMMUN

SURGE

HEPAT

EPIDE

ONCOL

Janeth C. Villanueva United States

Sylvie Ferrari‐Lacraz Switzerland

Hong Rae Cho South Korea

A S Rao United States

Espen Melum Norway

Evan A. Farkash United States

T. Mohanakumar United States

P. B. Carroll United States

Brigitte Bartsch Germany

Melissa Y. Yeung United States

Janeth C. Villanueva United States

Yuka Tanaka

510 ×0.7

IMMUN

370 ×0.8

SURGE

458 ×1.0

HEPAT

407 ×1.2

EPIDE

140 ×0.5

ONCOL

Citations per year, relative to Yuka Tanaka Yuka Tanaka (= 1×) peers Janeth C. Villanueva

Countries citing papers authored by Yuka Tanaka

Since Specialization

Citations

This map shows the geographic impact of Yuka Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuka Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuka Tanaka more than expected).

Fields of papers citing papers by Yuka Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuka Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuka Tanaka. The network helps show where Yuka Tanaka may publish in the future.

Co-authorship network of co-authors of Yuka Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yuka Tanaka. A scholar is included among the top collaborators of Yuka Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuka Tanaka. Yuka Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakano, Ryosuke, Masahiro Ohira, Koki Sato, et al.. (2024). Atherosclerosis Deteriorates Liver Ischemia/Reperfusion Injury Via Interferon Regulatory Factor-1 Overexpression in a Murine Model. Transplantation Proceedings. 56(3). 678–685. 2 indexed citations

Tanimine, Naoki, Masahiro Ohira, Ryosuke Nakano, et al.. (2024). Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver Transplantation. Cancers. 16(3). 533–533. 6 indexed citations

Imaoka, Yuki, Masahiro Ohira, Ryosuke Nakano, et al.. (2024). Interleukin‐33 and liver natural killer cells: A novel perspective on antitumor activity in liver fibrosis. Hepatology Research. 55(1). 115–129. 4 indexed citations

Sato, Koki, Masahiro Ohira, Yuki Imaoka, et al.. (2023). The aryl hydrocarbon receptor maintains antitumor activity of liver resident natural killer cells after partial hepatectomy in C57BL/6J mice. Cancer Medicine. 12(19). 19821–19837. 7 indexed citations

Ohira, Masahiro, Koki Sato, Yuki Imaoka, et al.. (2023). Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation. Transplantation Proceedings. 55(4). 906–912. 2 indexed citations

Imaoka, Yuki, Masahiro Ohira, Koki Sato, et al.. (2023). Impact of a new liver immune status index among patients with hepatocellular carcinoma after initial hepatectomy. Annals of Gastroenterological Surgery. 7(6). 987–996. 5 indexed citations

Nakamura, Risa, et al.. (2022). Leishmania major Strain-Dependent Macrophage Activation Contributes to Pathogenicity in the Absence of Lymphocytes. Microbiology Spectrum. 10(5). e0112622–e0112622. 5 indexed citations

Uchida, Takuro, Michio Imamura, Hiromi Abe‐Chayama, et al.. (2022). A novel cDNA‐uPA/SCID/Rag2^−/−/Jak3^−/− mouse model for hepatitis virus infection and reconstruction of human immune system. Journal of Viral Hepatitis. 30(3). 262–272. 1 indexed citations

Shimizu, Seiichi, Masahiro Ohira, Yuka Tanaka, et al.. (2022). Adoptive immunotherapy overcomes genetic susceptibility to bloodstream infections due to fc-gamma receptor polymorphisms after liver transplantation. American Journal of Transplantation. 22(10). 2392–2400. 3 indexed citations

10.

Ohira, Masahiro, Yuka Tanaka, Toshiharu Matsuura, et al.. (2021). Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma. Cancer Immunology Immunotherapy. 71(3). 589–599. 31 indexed citations

11.

Taguchi, Kazuhiro, Takashi Onoe, Tomoaki Yoshida, et al.. (2020). Tumor Endothelial Cell–Mediated Antigen-Specific T-cell Suppression via the PD-1/PD-L1 Pathway. Molecular Cancer Research. 18(9). 1427–1440. 38 indexed citations

12.

Ishiyama, Kohei, et al.. (2019). Cotransplantation of preactivated mesenchymal stem cells improves intraportal engraftment of islets by inhibiting liver natural killer cells in mice. American Journal of Transplantation. 19(10). 2732–2745. 19 indexed citations

13.

Nakano, Ryosuke, Masahiro Ohira, Takuya Yano, et al.. (2018). Hepatic irradiation persistently eliminates liver resident NK cells. PLoS ONE. 13(6). e0198904–e0198904. 11 indexed citations

14.

Ishiyama, Kohei, Yuka Tanaka, Tsuyoshi Kobayashi, et al.. (2018). Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis. Annals of Gastroenterological Surgery. 2(5). 383–393. 4 indexed citations

15.

Hirose, Takayuki, Yuka Tanaka, Hiroshi Sakai, et al.. (2017). PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice. PLoS ONE. 12(6). e0178765–e0178765. 18 indexed citations

16.

Tanimine, Naoki, Yuka Tanaka, Tsuyoshi Kobayashi, et al.. (2014). Quantitative Effect of Natural Killer–Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy. Cancer Immunology Research. 2(12). 1142–1147. 18 indexed citations

17.

Abe, Takashige, Ryuji Matsumoto, Takahiro Osawa, et al.. (2014). Outcome of Regional Lymphadenectomy in Accordance with Primary Tumor Location on Laparoscopic Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract: A Prospective Study. Journal of Endourology. 29(3). 304–309. 16 indexed citations

18.

Tahara, Hiroyuki, Kentaro Ide, Yuka Tanaka, et al.. (2010). Immunological Property of Antibodies against N -Glycolylneuraminic Acid Epitopes in Cytidine Monophospho– N -Acetylneuraminic Acid Hydroxylase-Deficient Mice. The Journal of Immunology. 184(6). 3269–3275. 34 indexed citations

19.

Ohira, Masahiro, Kohei Ishiyama, Yuka Tanaka, et al.. (2009). Adoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice. Journal of Clinical Investigation. 119(11). 3226–35. 71 indexed citations

20.

Tokita, Daisuke, Hideki Ohdan, Takashi Onoe, et al.. (2006). Liver Sinusoidal Endothelial Cells That Endocytose Allogeneic Cells Suppress T Cells with Indirect Allospecificity. The Journal of Immunology. 177(6). 3615–3624. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact